US Patent Issued to The Hospital for Sick Children, Centre for Addiction and Mental Health on Nov. 11 for "Biomarkers for autism spectrum disorders" (Canadian Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,467,093, issued on Nov. 11, was assigned to The Hospital for Sick Children (Toronto) and Centre for Addiction and Mental Health (Toronto).

"Biomarkers for autism spectrum disorders" was invented by Stephen W Scherer (Toronto) and John B Vincent (Toronto).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of determining the risk of ASD in an individual are provided which comprise identifying the presence of one or more genomic mutations in one or more of the genes, PTCHD1, SHANK3, NFIA, DPP6, DPP10, DYPD, GPR98, PQBP1, ZNF41 and FTSJ1."

The patent was filed on Jan. 21, 2022, under Application No. 17/581,371.

*For further information, including image...